FIELD: medicine.
SUBSTANCE: invention can be used in medicine and refers to 2-ethyl-6-methyl-3-hydroxypyridinium-gammalactone-2,3-dehydro-L-gulonate of formula
EFFECT: novel compound effective as a hypolipidemic agent is proposed.
1 cl, 2 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT EXHIBITING HEPATOPROTECTIVE, LIPID-REGULATING, ANTIISCHEMIC AND NEUROTROPIC ACTIVITY | 2018 |
|
RU2705575C1 |
2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
USE OF A PHARMACEUTICAL COMPOSITION WITH ANTIOXIDANT, VIRUCIDAL, IMMUNOSTULATING, ANTIHYPOXIC AND ANTI-AGGREGANT EFFECT | 2023 |
|
RU2808445C1 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
PHARMACEUTICAL FORMULATION IN SOLID DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2445091C1 |
2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE AND NICOTINIC ACID SALT, HAVING HYPOGLYCEMIC, HYPOLIPIDEMIC AND NEUROPROTECTIVE ACTIVITY AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2454406C2 |
Authors
Dates
2021-03-01—Published
2020-05-29—Filed